A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy

Παρόμοια τεκμήρια

• A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy
  ανά: Stearns, V, κ.ά.
  Έκδοση: (2009)
• Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo
  ανά: Yuan, Y, κ.ά.
  Έκδοση: (2008)
• Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
  ανά: O’Donnell, Robert T., κ.ά.
  Έκδοση: (2009)
• Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors
  ανά: Chun, Yong Soon, κ.ά.
  Έκδοση: (2012)
• Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
  ανά: Valle, J W, κ.ά.
  Έκδοση: (2005)